Elizabeth Kemmerer

Array ( [id] => 15432457 [patent_doc_number] => 20200030411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => Methods and Compositions for Inhibiting Skin Inflammation and Determining Cancer Susceptibility [patent_app_type] => utility [patent_app_number] => 16/335666 [patent_app_country] => US [patent_app_date] => 2017-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18935 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13386387 [patent_doc_number] => 20180244735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => Compositions and Methods of Use for Recombinant Human Secretoglobins [patent_app_type] => utility [patent_app_number] => 15/707934 [patent_app_country] => US [patent_app_date] => 2017-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7933 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15707934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14746837 [patent_doc_number] => 20190256592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-22 [patent_title] => BINDING AGENTS FOR USE IN THERAPY [patent_app_type] => utility [patent_app_number] => 16/333552 [patent_app_country] => US [patent_app_date] => 2017-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25571 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17044945 [patent_doc_number] => 11098113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-24 [patent_title] => Immunoglobulin single variable domains directed against macrophage migration inhibitory factor [patent_app_type] => utility [patent_app_number] => 16/333730 [patent_app_country] => US [patent_app_date] => 2017-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 38832 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12126279 [patent_doc_number] => 20180009865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'BMP-2 PEPTIDES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/704168 [patent_app_country] => US [patent_app_date] => 2017-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20341 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15704168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12125157 [patent_doc_number] => 20180008743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'BIORESORBABLE WOUND DRESSING' [patent_app_type] => utility [patent_app_number] => 15/696321 [patent_app_country] => US [patent_app_date] => 2017-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8852 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15696321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13702721 [patent_doc_number] => 20170362315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => Pan-ELR+ CXC CHEMOKINE ANTIBODIES [patent_app_type] => utility [patent_app_number] => 15/695338 [patent_app_country] => US [patent_app_date] => 2017-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7988 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14715563 [patent_doc_number] => 20190248845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF BONE ASSOCIATED DISEASES [patent_app_type] => utility [patent_app_number] => 16/326456 [patent_app_country] => US [patent_app_date] => 2017-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25959 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12151536 [patent_doc_number] => 20180022798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION' [patent_app_type] => utility [patent_app_number] => 15/671217 [patent_app_country] => US [patent_app_date] => 2017-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 74452 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15671217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12220754 [patent_doc_number] => 20180059115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-01 [patent_title] => 'METHODS FOR MONITORING POLYMORPHONUCLEAR MYELOID DERIVED SUPPRESSOR CELLS, AND COMPOSITIONS AND METHODS OF TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 15/668867 [patent_app_country] => US [patent_app_date] => 2017-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 35729 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15668867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12219220 [patent_doc_number] => 20180057579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-01 [patent_title] => 'ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 15/666317 [patent_app_country] => US [patent_app_date] => 2017-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 27520 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15666317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12060090 [patent_doc_number] => 20170336421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE' [patent_app_type] => utility [patent_app_number] => 15/660875 [patent_app_country] => US [patent_app_date] => 2017-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79425 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12051207 [patent_doc_number] => 20170327552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE' [patent_app_type] => utility [patent_app_number] => 15/660914 [patent_app_country] => US [patent_app_date] => 2017-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19087 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12204859 [patent_doc_number] => 20180050085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING MYELOFIBROSIS' [patent_app_type] => utility [patent_app_number] => 15/660421 [patent_app_country] => US [patent_app_date] => 2017-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 60247 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15666453 [patent_doc_number] => 10597444 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-24 [patent_title] => Anti-GDF15 antibodies [patent_app_type] => utility [patent_app_number] => 15/655263 [patent_app_country] => US [patent_app_date] => 2017-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 42 [patent_no_of_words] => 49142 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 370 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15655263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12204864 [patent_doc_number] => 20180050089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-22 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION' [patent_app_type] => utility [patent_app_number] => 15/650420 [patent_app_country] => US [patent_app_date] => 2017-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 75180 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12023669 [patent_doc_number] => 20170313768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'METHOD OF TREATING PRURITUS WITH IL-31 MONOCLONAL ANTIBODY FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 15/648252 [patent_app_country] => US [patent_app_date] => 2017-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28619 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11992426 [patent_doc_number] => 20170296581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'BONE MATRIX COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 15/639692 [patent_app_country] => US [patent_app_date] => 2017-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27811 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15639692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14519103 [patent_doc_number] => 10336798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-02 [patent_title] => Growth differentiation factor 15 (GDF-15) polypeptides [patent_app_type] => utility [patent_app_number] => 15/625891 [patent_app_country] => US [patent_app_date] => 2017-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 27208 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15625891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11962106 [patent_doc_number] => 20170266259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'System and Method for Multiphasic Release of Growth Factors' [patent_app_type] => utility [patent_app_number] => 15/616563 [patent_app_country] => US [patent_app_date] => 2017-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8962 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15616563 [rel_patent_id] =>[rel_patent_doc_number] =>)